TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE
Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent....
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PETER H. SCHAFER GEORGE W. MULLER PATRICIA E. W. ROHANE |
| description | Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
Se describen métodos de tratamiento, manejo o prevención de psoriasis o artritis psoriática. Los métodos engloban la administración de ciclopropil-N-(2-[(1S)-1-(3-etoxi-4-metoxifenil) -2-(metilsulfonil)etil]-3-oxoisoindolina-4-il}carboxamida, sola o en combinación con un segundo agente activo. También se describen composiciones farmacéuticas y formas de dosificación unitaria sencillas. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2010010334A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2010010334A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2010010334A3</originalsourceid><addsrcrecordid>eNqNi00KwjAUhLtxIeodgqu6eGCbXiCmqX2Q5pUkQrMQKRJXooLuxNN4UevPAYSBmfmYGSdPb5XwjTKeUcVaRxaFQ8fI_opHyYT1tUU_4I1Ds2YySE2tpTZoMHDP4Z5mbgEZpByUr6kLUEDzTW2tTNALyCF9k6DdhumK3uxTt8CBOkJHaErSaNTwDfohhV1RJxos1TQZHfrjNc5-PknmlfKyhng57-L10u_jKd52TZcvs-UgzgvB_xq9AFsLRv4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE</title><source>esp@cenet</source><creator>PETER H. SCHAFER ; GEORGE W. MULLER ; PATRICIA E. W. ROHANE</creator><creatorcontrib>PETER H. SCHAFER ; GEORGE W. MULLER ; PATRICIA E. W. ROHANE</creatorcontrib><description>Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
Se describen métodos de tratamiento, manejo o prevención de psoriasis o artritis psoriática. Los métodos engloban la administración de ciclopropil-N-(2-[(1S)-1-(3-etoxi-4-metoxifenil) -2-(metilsulfonil)etil]-3-oxoisoindolina-4-il}carboxamida, sola o en combinación con un segundo agente activo. También se describen composiciones farmacéuticas y formas de dosificación unitaria sencillas.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101008&DB=EPODOC&CC=MX&NR=2010010334A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101008&DB=EPODOC&CC=MX&NR=2010010334A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PETER H. SCHAFER</creatorcontrib><creatorcontrib>GEORGE W. MULLER</creatorcontrib><creatorcontrib>PATRICIA E. W. ROHANE</creatorcontrib><title>TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE</title><description>Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
Se describen métodos de tratamiento, manejo o prevención de psoriasis o artritis psoriática. Los métodos engloban la administración de ciclopropil-N-(2-[(1S)-1-(3-etoxi-4-metoxifenil) -2-(metilsulfonil)etil]-3-oxoisoindolina-4-il}carboxamida, sola o en combinación con un segundo agente activo. También se describen composiciones farmacéuticas y formas de dosificación unitaria sencillas.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi00KwjAUhLtxIeodgqu6eGCbXiCmqX2Q5pUkQrMQKRJXooLuxNN4UevPAYSBmfmYGSdPb5XwjTKeUcVaRxaFQ8fI_opHyYT1tUU_4I1Ds2YySE2tpTZoMHDP4Z5mbgEZpByUr6kLUEDzTW2tTNALyCF9k6DdhumK3uxTt8CBOkJHaErSaNTwDfohhV1RJxos1TQZHfrjNc5-PknmlfKyhng57-L10u_jKd52TZcvs-UgzgvB_xq9AFsLRv4</recordid><startdate>20101008</startdate><enddate>20101008</enddate><creator>PETER H. SCHAFER</creator><creator>GEORGE W. MULLER</creator><creator>PATRICIA E. W. ROHANE</creator><scope>EVB</scope></search><sort><creationdate>20101008</creationdate><title>TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE</title><author>PETER H. SCHAFER ; GEORGE W. MULLER ; PATRICIA E. W. ROHANE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2010010334A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PETER H. SCHAFER</creatorcontrib><creatorcontrib>GEORGE W. MULLER</creatorcontrib><creatorcontrib>PATRICIA E. W. ROHANE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PETER H. SCHAFER</au><au>GEORGE W. MULLER</au><au>PATRICIA E. W. ROHANE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE</title><date>2010-10-08</date><risdate>2010</risdate><abstract>Methods of treating, managing or preventing psoriasis or psoriatic arthritis are disclosed. The methods encompass the administration of cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsu lfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide, alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.
Se describen métodos de tratamiento, manejo o prevención de psoriasis o artritis psoriática. Los métodos engloban la administración de ciclopropil-N-(2-[(1S)-1-(3-etoxi-4-metoxifenil) -2-(metilsulfonil)etil]-3-oxoisoindolina-4-il}carboxamida, sola o en combinación con un segundo agente activo. También se describen composiciones farmacéuticas y formas de dosificación unitaria sencillas.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2010010334A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-{2-{(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSU LFONYL)ETHYL]-3-OXOISOINDOLINE-4-YL}CARBOXAMIDE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T23%3A45%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PETER%20H.%20SCHAFER&rft.date=2010-10-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2010010334A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |